Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection

Transplantation

Volumn 70, Issue 3, 2000, Pages 514-521

  Krasinskas, Alyssa M ^a   Eiref, Simon D ^a   McLean, Andrew D ^a   Kreisel, Daniel ^a   Gelman, Andrew E ^a   Popma, Sicco H ^a   Moore, Jonni S ^a   Rosengard, Bruce R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 6 Silverstein Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PATHOGENESIS; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; VASCULAR DISEASE;

EID: 0034663756     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008150-00020     Document Type: Article

References (29)

1. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors
2. Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors
3. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo
4. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse
5. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
6. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts
7. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC
8. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection
9. Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction
10. Properties of purified T cell subsets. II. In vivo responses to class I versus class II H-2 differences
11. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice
12. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
13. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of 'major histocompatibility complex-deficient' skin grafts
14. Survival of MHC-deficient mouse heterotopic cardiac allografts
15. Graft adaptation: Studies on possible mechanisms in long-term surviving rat renal allografts
16. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells
17. Creation of chimeric hearts via bone marrow transplantation: A new tool for testing the 'passenger leukocyte' hypothesis
18. Enrichment of dendritic cells by plastic adherence and EA rosetting
19. Improved technique of heart transplantation in rats
20. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model
21. Cell migration, chimerism, and graft acceptance
22. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
23. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats
24. Deletion of spontaneous rat liver allograft acceptance by donor irradiation
25. Combined simultaneous kidney/bone marrow transplantation
26. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients
27. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
28. Chronically rejected rat kidney allografts induce donor-specific tolerance
29. Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model